Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

830 résultats trouvés

Mechanisms of glutamatergic neuronal dysfunction in genetic models of ALS

This project will focus on comprehensively studying impaired transmission of signals (from the brain) at the location where neurons and muscles meet, called the neuromuscular junction.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Québec
DATE DE DÉBUT
2017

Development and validation of reagent kits for commercial high-throughput screening of PPI s and PPI inhibitors

Membrane proteins are biological molecules of incredible importance, playing diverse roles in many processes critical to life.


TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Neurotechnologie
Concours
CQDM - Brain Canada - Quantum Leap
Province
Ontario
DATE DE DÉBUT
2017

The Aging Brain: Circadian, Transcriptomic, and Epigenomic Dimensions

One of the most important questions of biomedical research is “why do we ail as we age?”.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2017

Montreal integrated neuropsychiatric cohort: Identifying subtypes of Autism and Schizophrenia integrating genomics, endophenotypes, and cohorts of high-risk genetic variants

Autism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Multiple
Province
Québec
DATE DE DÉBUT
2017

Using synthetic antibody parts to construct antibody-based imaging devices – anti-EGFR molecular targeted imaging probes for diagnosing and monitoring glioblastoma

To improve outcomes in brain cancer, better tools are needed to diagnose brain cancer, surgically remove brain tumours and monitor how they respond to therapy.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Saskatchewan
DATE DE DÉBUT
2017

Molecular characterization of transcriptional repressor capicua in GBM

Malignant gliomas, including oligodendrogliomas (OD) and glioblastomas (GBM), are currently incurable brain tumours with few effective treatment options.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2017

Integrative discovery of ion channels as drug targets in glioblastoma

Ion channel (IC) proteins are known to be involved in different human diseases such as heart and brain disorders.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2017

Quantitative MRI as a biomarker of tumour resistance to radiation treatment in brain metastasis

Brain metastasis occurs in 20% to 40% of all cancer patients and impacts quality of life and survival. Stereotactic radiosurgery (SRS), which involves delivering high doses of radiation to the tumour, is the preferred treatment for these patients.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2017

Advancing biology based therapies for rhabdoid brain tumours

Rhabdoid brain tumours are the most common brain cancers in infants.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2017

Mouse brain imaging for neurodevelopmental disorders

The project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Développement neurologique
Province
Ontario
DATE DE DÉBUT
2016